Bajaj HealthCare Limited (BOM:539872)
India · Delayed Price · Currency is INR 366.95
-9.65 (-2.56%)
At close: Feb 12, 2026
Bajaj HealthCare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 6,124 | 5,426 | 4,734 | 6,458 | 6,799 | 6,570 |
| 6,124 | 5,426 | 4,734 | 6,458 | 6,799 | 6,570 | |
Revenue Growth (YoY) | 17.32% | 14.61% | -26.69% | -5.01% | 3.49% | 59.96% |
Cost of Revenue | 3,372 | 2,947 | 2,574 | 3,849 | 4,995 | 4,692 |
Gross Profit | 2,753 | 2,479 | 2,160 | 2,609 | 1,804 | 1,878 |
Selling, General & Admin | 630.01 | 579.02 | 446.19 | 432.72 | 412.63 | 351.75 |
Other Operating Expenses | 1,184 | 1,076 | 949.25 | 1,060 | 172.21 | 139.45 |
Operating Expenses | 2,089 | 1,934 | 1,672 | 1,665 | 761.21 | 652.44 |
Operating Income | 663.95 | 544.55 | 488.35 | 943.37 | 1,043 | 1,226 |
Interest Expense | -199.61 | -251.22 | -290.53 | -163.99 | -110.01 | -60.76 |
Interest & Investment Income | 5.1 | 5.1 | 3.29 | 4.28 | 1.72 | 1.67 |
Currency Exchange Gain (Loss) | 101.38 | 101.38 | 18.77 | - | -19.39 | 44.02 |
Other Non Operating Income (Expenses) | 14.03 | 30.58 | -6.94 | -10.09 | -17.81 | -22.62 |
EBT Excluding Unusual Items | 584.85 | 430.39 | 212.93 | 773.57 | 897.66 | 1,188 |
Gain (Loss) on Sale of Assets | 3.35 | 3.35 | 0.36 | 0.04 | - | 0.12 |
Asset Writedown | - | - | -443.28 | - | - | - |
Other Unusual Items | - | - | - | - | -1 | - |
Pretax Income | 614.54 | 460.08 | -166.76 | 781.82 | 896.85 | 1,188 |
Income Tax Expense | 91.38 | 30.79 | -23.49 | 146.5 | 182.99 | 357.11 |
Earnings From Continuing Operations | 523.16 | 429.29 | -143.27 | 635.33 | 713.86 | 831.09 |
Earnings From Discontinued Operations | -25.22 | -34.33 | -694.67 | -205.08 | - | - |
Net Income | 497.95 | 394.96 | -837.93 | 430.24 | 713.86 | 831.09 |
Net Income to Common | 497.95 | 394.96 | -837.93 | 430.24 | 713.86 | 831.09 |
Net Income Growth | - | - | - | -39.73% | -14.11% | 229.32% |
Shares Outstanding (Basic) | 32 | 30 | 28 | 28 | 28 | 28 |
Shares Outstanding (Diluted) | 32 | 30 | 28 | 28 | 28 | 28 |
Shares Change (YoY) | 12.68% | 9.09% | - | - | - | - |
EPS (Basic) | 15.76 | 13.29 | -30.36 | 15.59 | 25.87 | 30.11 |
EPS (Diluted) | 15.38 | 13.12 | -30.36 | 15.59 | 25.87 | 30.11 |
EPS Growth | - | - | - | -39.73% | -14.09% | 229.28% |
Free Cash Flow | - | 100.82 | 620.08 | -1,158 | -786.19 | -702.3 |
Free Cash Flow Per Share | - | 3.35 | 22.47 | -41.95 | -28.49 | -25.45 |
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | 1.500 | 0.875 |
Dividend Growth | - | - | - | -33.33% | 71.43% | - |
Gross Margin | 44.95% | 45.68% | 45.63% | 40.39% | 26.54% | 28.59% |
Operating Margin | 10.84% | 10.04% | 10.32% | 14.61% | 15.34% | 18.66% |
Profit Margin | 8.13% | 7.28% | -17.70% | 6.66% | 10.50% | 12.65% |
Free Cash Flow Margin | - | 1.86% | 13.10% | -17.93% | -11.56% | -10.69% |
EBITDA | 902.24 | 814.6 | 800.76 | 1,216 | 1,220 | 1,387 |
EBITDA Margin | 14.73% | 15.01% | 16.91% | 18.82% | 17.94% | 21.11% |
D&A For EBITDA | 238.29 | 270.05 | 312.41 | 272.35 | 176.37 | 161.24 |
EBIT | 663.95 | 544.55 | 488.35 | 943.37 | 1,043 | 1,226 |
EBIT Margin | 10.84% | 10.04% | 10.32% | 14.61% | 15.34% | 18.66% |
Effective Tax Rate | 14.87% | 6.69% | - | 18.74% | 20.40% | 30.05% |
Revenue as Reported | 6,302 | 5,620 | 4,821 | 6,474 | 6,813 | 6,639 |
Advertising Expenses | - | 8.41 | 7.66 | 6.58 | 0.94 | 5.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.